United States of America et al v. Diabetic Care Rx, LLC et al

  1. March 16, 2018

    Private Equity FCA Suit More Likely Outlier Than Omen

    The U.S. Department of Justice's unusual decision to name a private equity firm as a defendant in a False Claims Act suit against one of the firm's portfolio companies is an issue all private equity firms should be aware of, although the alleged circumstances of the case may mean similar complaints will be few and far between, attorneys say.

  2. February 23, 2018

    US Steps Into Tricare FCA Suit Against Pharmacy, PE Owner

    The government has intervened in a False Claims Act suit accusing a Florida compounding pharmacy and its private equity fund owner of running a kickback scheme that induced Tricare to pay more than $68 million for medically unnecessary prescriptions, the U.S. Department of Justice announced Friday.